9-35682882-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP4_StrongBP6_ModerateBS2
The NM_213674.1(TPM2):c.773-719G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000685 in 1,465,118 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.00070 ( 0 hom., cov: 33)
Exomes 𝑓: 0.00068 ( 1 hom. )
Consequence
TPM2
NM_213674.1 intron
NM_213674.1 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.105
Genes affected
TPM2 (HGNC:12011): (tropomyosin 2) This gene encodes beta-tropomyosin, a member of the actin filament binding protein family, and mainly expressed in slow, type 1 muscle fibers. Mutations in this gene can alter the expression of other sarcomeric tropomyosin proteins, and cause cap disease, nemaline myopathy and distal arthrogryposis syndromes. Alternatively spliced transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Mar 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -10 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.87).
BP6
Variant 9-35682882-C-T is Benign according to our data. Variant chr9-35682882-C-T is described in ClinVar as [Benign]. Clinvar id is 1879734.Status of the report is criteria_provided_single_submitter, 1 stars.
BS2
High AC in GnomAd4 at 107 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TPM2 | NM_001301226.2 | c.773-719G>A | intron_variant | NP_001288155.1 | ||||
TPM2 | NM_213674.1 | c.773-719G>A | intron_variant | NP_998839.1 | ||||
TPM2 | NM_003289.4 | c.*277G>A | downstream_gene_variant | ENST00000645482.3 | NP_003280.2 | |||
TPM2 | NM_001301227.2 | c.*277G>A | downstream_gene_variant | NP_001288156.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000703 AC: 107AN: 152114Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
107
AN:
152114
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000659 AC: 89AN: 135044Hom.: 0 AF XY: 0.000729 AC XY: 52AN XY: 71344
GnomAD3 exomes
AF:
AC:
89
AN:
135044
Hom.:
AF XY:
AC XY:
52
AN XY:
71344
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000683 AC: 897AN: 1313004Hom.: 1 Cov.: 32 AF XY: 0.000702 AC XY: 452AN XY: 644016
GnomAD4 exome
AF:
AC:
897
AN:
1313004
Hom.:
Cov.:
32
AF XY:
AC XY:
452
AN XY:
644016
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000703 AC: 107AN: 152114Hom.: 0 Cov.: 33 AF XY: 0.000619 AC XY: 46AN XY: 74292
GnomAD4 genome
AF:
AC:
107
AN:
152114
Hom.:
Cov.:
33
AF XY:
AC XY:
46
AN XY:
74292
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Oct 01, 2022 | TPM2: BS1, BS2 - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at